BD Medical Successfully Concludes Participation in the 6th China International Import Expo, Showcasing Innovations to Advance High-Quality Development of China's Medical Device Industry

ShanghaiNovember 13, 2023PR Newswire -- Today, the 6th China International Import Expo (hereinafter referred to as "CIIE") concluded as scheduled at the National Exhibition and Convention Center (Shanghai). BD, a global medical technology giant and key participant in the CIIE for four consecutive years as well as the president unit of the Medical Device Committee of the CIIE Alliance, showcased its central theme of "Dedicated to Innovation, Pioneering the Future of Health" through a creative Ferris wheel concept, four major medical technology thematic scenarios, an intelligent and digital visiting experience, and interactive online and offline activities. Highlighting its comprehensive commitment to safeguarding patient health with innovative practices in China, BD presented more than ten global and China product launches, pre-release products, along with nearly a hundred star innovative medical products.

The CIIE, held annually as a high-level platform for opening up and high-quality development, has further promoted the open cooperation and exchange of many multinational enterprises in China, including the medical device industry.Deng Jianmin, Global Senior Vice President of BD and General Manager of Greater ChinaStated: "As a participant and beneficiary of the CIIE, BD has personally experienced the platform advantages of the CIIE in linking China and global development, as well as its spillover effects on innovative products and cutting-edge technologies. BD has completed the signing for participation in the 7th CIIE. We will adhere to our strategic concept of ‘Rooted in China, serving China; based in China, serving the world,’ continuously leveraging the CIIE to bring more new products, new technologies, and new services into China. With innovation, cooperation, and win-win approaches, we aim to accelerate the creation of a local industrial innovation ecosystem, collaborate with multiple partners to benefit more Chinese patients, and contribute to the construction of Healthy China."

Multiple New Product Debuts Unveiled, Innovation Leads Local Manufacturing

During the 6th CIIE, the BD booth focused on four major themed exhibition areas: "Frontier Life Science Exploration, Clinical Testing and Health Management, Innovative Ecosystem for Patient Procedures, and Precision Oncology Screening and Treatment," along with several new product launch events.

Among them,Harnessing the power of both local Chinese and global resources for research, development, and production.PowerMe® Midline Catheter via Peripheral InsertionThe global premiere release, by Becton, Dickinson and CompanyDeveloped by a Chinese team and launched in both domestic and international marketsBD Liverty™ Adjustable Bend Transjugular Puncture DeviceThe release has attracted widespread attention.

PowerMe® Midline Catheter via Peripheral Insertion

PowerMe® Midline Catheter, which was officially approved for marketing this year, is a new-generation infusion "miracle device" capable of protecting patients' blood vessels. With its high-pressure injection resistance and up to 30-day venous indwelling duration, it can meet the high-pressure treatment and routine infusion needs of patients during one hospitalization cycle, offering excellent clinical value for controlling treatment costs and improving patient experience.

The BD Liverty™ Steerable Access Kit features the world’s first steerable rigid cannula, enabling precise and controllable in vivo adjustments. This significantly improves the most challenging step of intrahepatic portal vein puncture during surgery, making the procedure safer and more efficient.

BD Liverty™ Adjustable Bend Puncture Kit

In addition, BDFirst domestically producedHigh-Cost-Performance Portable Clinical Flow Cytometer——Matecyte™ Clinical Flow CytometerAlso made its debut at the CIIE booth this year, gathering with the aforementioned high-quality locally produced and locally innovative products on the CIIE stage, showcasing the innovative achievements of BD's "Rooted in China, Serving the World" localization strategy.

Matecyte™ Clinical Flow Cytometer

Multiple Collaborations Signed to Deepen Local Production and Research Partnerships

In addition to showcasing innovative products from its global headquarters and locally produced in China, during this year's CIIE, BD will also finalize several intended cooperation agreements and signing ceremonies, including FACSLyric, S8, HT Xpress, cooperation with Prenetics, the BD Single-Cell Automated Library Preparation Workstation, a strategic cooperation memorandum with Waigaoqiao Group, an e-commerce signing with StatLock, distributor signings with Sinopharm Group and Xiehe Medical, as well as annual cooperation signings with major hospitals. While expanding industry partner networks in areas such as product development and commercial growth, BD is driving the integrated development of China's medical device industry through technological innovation advantages.

BD Medical's On-site Signing Ceremony with Partners

Medical Innovation Incubation Zone

BD has served as the President Unit of the Medical Device Professional Committee of the CIIE Exhibition Alliance for three consecutive years. Since 2021, BD has taken the lead in assisting the medical exhibition area of the CIIE to establish an innovation incubation zone, actively gathering and connecting "industry-academia-research-medical-policy" ecosystem partners to build a deep-level national market access and empowerment system. By building a global medical ecosystem platform, BD helps small and medium-sized medical technology innovation companies from around the world take root in China, achieving transformations from "exhibitors" to "investors," "exhibits" to "products," and "products" to "commodities." This effort demonstrates BD’s firm determination to resonate with the high-quality development of China's healthcare industry through practical results in fostering local innovation and production in the medical device ecosystem.